Alacrita

Waltham, United States Founded: 2009 • Age: 17 yrs
Offers consulting services for pharma and biotech development and business strategies.

About Alacrita

Alacrita is a Healthcare company based in Waltham (United States) founded in 2009. It offers consulting services for pharma and biotech development and business strategies. It operates on a B2B model. Its chief executive is Rob Johnson. Alacrita offers products and services including Product Development, Research & IP Evaluation, Clinical Development, and Business Development. Its focus areas include Pharmaceutical, Commercialization, Strategy and Biotech. Its legal entity is Alacrita Holdings Limited. Its competitors include Indegene, IntegriChain, Clinigen, Zuellig Pharma and Fishawack and 4 more; 4 of its 9 listed competitors have raised funding.

Company details

Alacrita is a consulting firm specializing in the pharmaceutical and biotechnology sectors, providing services such as product development, research evaluation, clinical strategies, and regulatory affairs. They support clients through expert networks for RD and commercialization, including opportunity mapping and deal-making. Based in London, UK, and Cambridge, MA, USA, they serve biotechs, pharmaceutical companies, investors, and tech transfer offices, leveraging multidisciplinary expertise to deliver tailored solutions.

  • Headquarters Waltham, United States
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website alacrita.com
  • Social X
  • Legal Name Alacrita Holdings Limited

Products & Services of Alacrita

Alacrita offers a comprehensive portfolio of products and services, including Product Development, Research & IP Evaluation, Clinical Development, and Business Development.

Product Development
Consulting

Support for pharma product development and optimization stages

Research & IP Evaluation
Consulting

Evaluation of research and intellectual property for biotech

Clinical Development
Consulting

Assistance in clinical trials and strategy execution

Business Development
Consulting

Services for asset scouting and deal-making in pharma

People of Alacrita

12 people are tracked at Alacrita (9 in leadership, 3 in team).

NameRoleGroup
Anthony Walker
Managing PartnerLeadership
Rob Johnson
CEOLeadership
Christine Mccarthy
PartnerLeadership
Stuart Hendry
PartnerLeadership
William Slichenmyer
PartnerLeadership
Mark Philip
PartnerLeadership
Pierre Dodion
PartnerLeadership
Gary Mansfield
PartnerLeadership
Cort H.
Head Of Marketing & OutreachLeadership
Simon Turner
Strategic AdvisorTeam
Colin Wyatt
AssociateTeam
George Vella
AssociateTeam
Premium access

Complete people profiles for Alacrita

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Competitors of Alacrita

Alacrita has 9 listed competitors in our database, 4 of them funded. They include Indegene, IntegriChain, Clinigen, Zuellig Pharma and Fishawack, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
indegene.com1998Princeton, United States$220M350
Suite solutions are provided for payers and healthcare providers.
integrichain.com2005Philadelphia, United States$2M320
Inventory, order and customer relationship management solution for life science suppliers.
clinigengroup.com2010Burton-on-trent, United Kingdom––
Specialty medicines are supplied via clinical trials and access programs.
zuelligpharma.com1992Singapore––
Healthcare access in Asia is enhanced by Zuellig Pharma.
fishawack.com2001Brighton, United Kingdom$23.59M45
Fully integrated cross-border services are delivered to global pharmaceutical organizations.
sciencegroup.com1995Cambridge, United Kingdom–431
Technology-based consultancy and product development services are provided.
clearviewhcp.com2008Newton, United States–381
Strategic consulting services are provided to life sciences companies.
diaceutics.com2005Belfast, United Kingdom–133
Precision medicine integration is facilitated through analytics and services.
sancilio.com2005Riviera Beach, United States$27.25M–
Innovative drug candidates are developed using proprietary Advanced Lipid Technologies.
Premium access

Detailed competitors of Alacrita

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Alacrita

Websites that share an audience with Alacrita (alacrita.com).

Similar websites

Websites whose visitors overlap most with Alacrita. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
lambda-cro.com
95%
38.8K#490,207View details
trilogywriting.com
91%
6.3K#3,520,858View details
syneoshealth.com
90%
199.6K#198,509View details
lindushealth.com
87%
62.9K#570,947View details
askbio.com
84%
14.3K#2,158,975View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 8 similar websites and full traffic analytics for Alacrita

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 8 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Pharmaceuticals & Distribution

10 companies that operate in the same segment as Alacrita (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical products are manufactured and marketed worldwide.
1891Kenilworth, Warwickshire, United Kingdom–USD 64.93 B781
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United States–USD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United States–USD 61.16 B55,000
Traditional pharmaceutical medicines are developed for multiple health fields.
1876United States–USD 65.18 B47,000
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987Foster City, California, United States–USD 29.45 B17,600
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 213.52 MUSD 29.62 M225
Developer of medical devices, generic pharmaceuticals, and nutrition products
1888Libertyville, Illinois, United States–USD 44.33 B3,710
Medicines and health products are retailed through pharmacy outlets.
2006Hyderabad, Telangana, IndiaUSD 268.78 MUSD 734.57 M25,010
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Alacrita

Premium access

Complete news archive for Alacrita

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alacrita

Alacrita was founded in 2009.

Alacrita is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.

Rob Johnson is the current CEO of Alacrita.

Alacrita is a consulting firm specializing in the pharmaceutical and biotechnology sectors, providing services such as product development, research evaluation, clinical strategies, and regulatory affairs. They support clients through expert networks for RD and commercialization, including opportunity mapping and deal-making. Based in London, UK, and Cambridge, MA, USA, they serve biotechs, pharmaceutical companies, investors, and tech transfer offices, leveraging multidisciplinary expertise to deliver tailored solutions.

Alacrita's top competitors include Indegene, Zuellig Pharma and IntegriChain.

Alacrita offers Product Development, Research & IP Evaluation, Clinical Development, and Business Development.

Alacrita operates through Alacrita Holdings Limited.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available